Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs IMRT for Low or Intermediate Risk Prostate Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Indications Prostate cancer
- Focus Biomarker
- Acronyms PARTIQoL
- 09 Sep 2020 Biomarkers information updated
- 18 Sep 2013 Planned number of patients changed from 461 to 400 as reported by ClinicalTrials.gov.
- 07 Jan 2013 Actual initiation date changed from Jun 2012 to Jul 2012 as reported by ClinicalTrials.gov.